The effects of switching from dolutegravir/abacavir/
lamivudine to bictegravir/emtricitabine/tenofovir
alafenamide in virologically suppressed people living with
HIV on neuropsychiatric symptoms: preliminary findings
from a randomised study

Barbara Rossetti; M Ferrara; L Taramasso; F Bai; F Lombardi; Nicoletta Ciccarelli; M Durante; F Alladio; I Rancan; F Montagnani; A Di Biagio; A d’Arminio Monforte; M Zazzi; M Fabbiani

The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study

Barbara Rossetti, M Ferrara, L Taramasso, F Bai, F Lombardi, Nicoletta Ciccarelli, M Durante, F Alladio, I Rancan, F Montagnani, A Di Biagio, A d’Arminio Monforte, M Zazzi, M Fabbiani

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Abstract

Lingua originale	English
pagine (da-a)	161-161
Numero di pagine	1
Rivista	EJIAS
Volume	25
Stato di pubblicazione	Pubblicato - 2022

Keywords

neuropsychiatric symptoms

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Rossetti, B., Ferrara, M., Taramasso, L., Bai, F., Lombardi, F., Ciccarelli, N., Durante, M., Alladio, F., Rancan, I., Montagnani, F., Biagio, A. D., Monforte, A. DA., Zazzi, M., & Fabbiani, M. (2022). The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study. EJIAS, 25, 161-161.

@article{f9dc4d6e8f5348c4af8b8bda6b3c9abb,

title = "The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study",

keywords = "neuropsychiatric symptoms, neuropsychiatric symptoms",

author = "Barbara Rossetti and M Ferrara and L Taramasso and F Bai and F Lombardi and Nicoletta Ciccarelli and M Durante and F Alladio and I Rancan and F Montagnani and Biagio, {A Di} and Monforte, {A d{\textquoteright}Arminio} and M Zazzi and M Fabbiani",

year = "2022",

language = "English",

volume = "25",

pages = "161--161",

journal = "EJIAS",

publisher = "New York, N.Y.] : Medscape, [2004]-",

}

Rossetti, B, Ferrara, M, Taramasso, L, Bai, F, Lombardi, F, Ciccarelli, N, Durante, M, Alladio, F, Rancan, I, Montagnani, F, Biagio, AD, Monforte, ADA, Zazzi, M & Fabbiani, M 2022, 'The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study', EJIAS, vol. 25, pagg. 161-161.

The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study. / Rossetti, Barbara; Ferrara, M; Taramasso, L et al.
In: EJIAS, Vol. 25, 2022, pag. 161-161.

Risultato della ricerca: Contributo in rivista › Abstract

TY - JOUR

T1 - The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study

AU - Rossetti, Barbara

AU - Ferrara, M

AU - Taramasso, L

AU - Bai, F

AU - Lombardi, F

AU - Ciccarelli, Nicoletta

AU - Durante, M

AU - Alladio, F

AU - Rancan, I

AU - Montagnani, F

AU - Biagio, A Di

AU - Monforte, A d’Arminio

AU - Zazzi, M

AU - Fabbiani, M

PY - 2022

Y1 - 2022

KW - neuropsychiatric symptoms

UR - http://hdl.handle.net/10807/218465

M3 - Meeting Abstract

VL - 25

SP - 161

EP - 161

JO - EJIAS

JF - EJIAS

ER -